Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M475Revenue $M69.6Net Margin (%)-202.6Z-Score-6.4
Enterprise Value $M468EPS $-0.6Operating Margin %-179.7F-Score1
P/E(ttm))0Cash Flow Per Share $-0.2Pre-tax Margin (%)-202.6Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %-11.5Quick Ratio2.3Cash flow > EarningsY
Price/Sales10.65-y EBITDA Growth Rate %-15.1Current Ratio2.3Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-60.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M132ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARRY

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ARRYJean-Marie Eveillard 2011-12-31 Sold Out -0.0024%$1.77 - $2.83
($2.28)
$ 3.658%Sold Out0
ARRYGeorge Soros 2011-12-31 Sold Out -0.0008%$1.77 - $2.83
($2.28)
$ 3.658%Sold Out0
ARRYGeorge Soros 2011-09-30 Buy $1.99 - $2.62
($2.24)
$ 3.661%New holding, 22400 sh.22,400
ARRYGeorge Soros 2011-06-30 Sold Out $2.06 - $3.21
($2.7)
$ 3.633%Sold Out0
ARRYJean-Marie Eveillard 2011-06-30 Add$2.06 - $3.21
($2.7)
$ 3.633%Add 150%250,000
ARRYGeorge Soros 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.620%New holding, 14400 sh.14,400
ARRYJean-Marie Eveillard 2011-03-31 Buy $2.7 - $3.29
($3)
$ 3.620%New holding, 100000 sh.100,000
ARRYJean-Marie Eveillard 2010-09-30 Sold Out -0.01%$2.67 - $3.44
($3.02)
$ 3.619%Sold Out0
ARRYJean-Marie Eveillard 2010-06-30 Reduce-0.01%$2.66 - $4.02
($3.41)
$ 3.66%Reduce -54.96%450,000
ARRYJean-Marie Eveillard 2009-12-31 Add0.01%$1.72 - $2.81
($2.2)
$ 3.664%Add 62.96%999,132
ARRYJean-Marie Eveillard 2008-12-31 Add0.02%$3.23 - $4.92
($3.9)
$ 3.6-8%Add 102.65%573,865
ARRYJean-Marie Eveillard 2008-09-30 Reduce-0.01%$5.18 - $8.51
($7.3)
$ 3.6-51%Reduce -33.86%283,181
ARRYJean-Marie Eveillard 2008-06-30 Add0.01%$4.66 - $7.13
($6)
$ 3.6-40%Add 62.74%428,181
ARRYJean-Marie Eveillard 2008-03-31 Add$5.36 - $8.1
($6.4)
$ 3.6-44%Add 128.78%263,100
ARRYJean-Marie Eveillard 2007-12-31 Add$8.5 - $12.15
($10.7)
$ 3.6-66%Add 76.92%115,000
ARRYJean-Marie Eveillard 2007-09-30 Buy 0.01%$9.72 - $12.76
($11.4)
$ 3.6-68%New holding, 65000 sh.65,000
ARRYJean-Marie Eveillard 2007-06-30 Sold Out -0.01%$11.46 - $14
($12.7)
$ 3.6-72%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ARRY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARRY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MOORE JOHN RVP, General Counsel 2013-11-29Sell11,666$5.79-37.82 view
MOORE JOHN RVP, General Counsel 2013-11-13Sell200$5.79-37.82 view
Ratcliffe LiamDirector 2013-09-27Sell1,125,728$6-40 view
Ratcliffe LiamDirector 2013-09-16Sell1,673,172$6.08-40.79 view
Ratcliffe LiamDirector 2013-09-06Sell577,286$5.79-37.82 view
MOORE JOHN RVP, General Counsel 2013-08-02Sell75,384$7.02-48.72 view
MOORE JOHN RVP, General Counsel 2013-07-23Sell5,000$6.5-44.62 view
MOORE JOHN RVP, General Counsel 2012-10-08Sell28,547$5.69-36.73 view
CARRUTHERS MICHAELCFO 2012-02-10Sell1,545$2.6535.85 view
CARRUTHERS MICHAELCFO 2012-01-12Sell1,994$2.0674.76 view

Press Releases about ARRY :

    Quarterly/Annual Reports about ARRY:

    News about ARRY:

    Articles On GuruFocus.com
    comment on ARRY Mar 02 2013 
    Re: ARRY Aug 29 2011 
    Drug Penny Stock Aug 23 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,310 Shares Mar 16 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,403 Shares Feb 11 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,272 Shares Jan 13 2011 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,256 Shares Dec 10 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,220 Shares Nov 12 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,225 Shares Oct 13 2010 
    Array BioPharma Inc. (ARRY) CFO Michael Carruthers sells 1,309 Shares Jul 23 2010 

    More From Other Websites
    ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 29 2014
    Phase 2 Trial Of Binimetinib In NRAS Melanoma Shows Promising Clinical Activity Sep 29 2014
    ARRAY BIOPHARMA INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in... Sep 12 2014
    Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer Sep 11 2014
    Array BioPharma To Present At The Morgan Stanley 2014 Global Healthcare Conference Sep 03 2014
    ARRAY BIOPHARMA INC Financials Aug 22 2014
    ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Aug 20 2014
    Array BioPharma Falls Despite Narrower-than-Expected Q4 Loss Aug 15 2014
    ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report Aug 15 2014
    Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today Aug 12 2014
    ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 12 2014
    Q4 2014 Array BioPharma Inc. Earnings Release - Before Market Open Aug 12 2014
    Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 Aug 12 2014
    Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On... Jul 28 2014
    Array BioPharma, Inc. (ARRY) Jumps: Stock Surges 10.7% Higher Jul 24 2014
    Array BioPharma To Present At The Wells Fargo Securities 2014 Healthcare Conference Jun 11 2014
    ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 02 2014
    Array BioPharma receives orphan status for kinase inhibitor Jun 02 2014
    Two Array-Invented MEK Inhibitors Showcased At ASCO Jun 02 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK